Asymptomatic Employee Screening for SARS-CoV-2: Implementation of and Reactions to an Employer-Based Testing Program. release_n3gczz74wfhyxav3irhqbmm4ji

by Laura Goetz, Tyler L DeLaughder, Kathleen L Kennedy, Nicholas J. Schork, Timothy McDaniel, Jeffrey Trent, David Engelthaler

Released as a post by Cold Spring Harbor Laboratory.

2020  

Abstract

Introduction. Asymptomatic testing for SARS-CoV-2 among healthcare workers or other essential personnel could remove infected carriers from the workforce, decreasing chances for transmission and workplace outbreaks. Results from one-time testing programs have been reported but data regarding longitudinal testing, including information about employees reactions to such programs, is not readily available. Methods. To identify asymptomatic carriers of SARS-CoV-2, we implemented a longitudinal screening program for critical on-site employees within our research institute in early April 2020. We conducted a survey of both on-site employees and those working from home in order to measure their reactions to the testing program. Statistical analysis of the survey was conducted with general linear regression and Pearsons Chi-Square tests. Results. Despite an ongoing high community prevalence rate of COVID-19, to date only two asymptomatic employees tested positive out of 1050 tests run during 7 months of the program. However, 12 symptomatic employees not participating in the program have tested positive. The employee survey was completed by 132/306 (43%) employees, with 93% agreeing that asymptomatic employee screening led to a better and safer working environment and 75% agreeing with on-site public health measures to help contain the virus, but only 58% feeling COVID-19 was a serious threat to their health. Conclusion. Our results suggest that a longitudinal asymptomatic employee screening program for SARS-CoV-2 can be accepted by employees and can be used to maintain the health of the workforce, potentially keeping positivity rates below community levels in the face of the ongoing COVID-19 pandemic.
In application/xml+jats format

Archived Files and Locations

application/pdf   264.2 kB
file_y4clovdfzreajla33asnwzng54
www.medrxiv.org (repository)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  post
Stage   unknown
Date   2020-11-10
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: fd6e2537-cea1-44cf-87f1-eac5a540e007
API URL: JSON